Professional Documents
Culture Documents
Scholarship@Western
Medical Biophysics Publications
Medical Biophysics
1-1-2015
SCIENTIFIC FOUNDATION
290
Operative Technique
Control Group (n = 6)
On the defect side (right parietal bone), a 4-mm calvarial defect was created, in addition to an adjacent full-thickness crescent
defect. On the treatment (sham) side (left parietal), a single 4-mm
Copyright 2014 Mutaz B. Habal, MD. Unauthorized reproduction of this article is prohibited.
Statistical Analysis
Statistical analysis was performed using SPSS software, version 17 (IBM, Somers, NY). Within the groups, BMC was compared between defect and treatment (sham or bone graft) sides at
each time point using paired t-tests. Differences in BMC between
treatment and defect (T-D) sides were compared between the groups
using 1-way analysis of variance (ANOVA) at each time point. If a
difference was found using ANOVA, post hoc comparisons were
performed using the Tukey honestly significant difference t-test to
identify the difference between pairs. Nonparametric analysis was
Copyright 2014 Mutaz B. Habal, MD. Unauthorized reproduction of this article is prohibited.
291
Power et al
Week 2
Week 6
Week 12
Control
0.917
0.508
0.074
0.028*
0.169
0.028*
0.028*
0.333
0.037*
N-V
VAS
Wilcoxon 2-sample tests comparing BMC of treatment (sham or bone graft) versus
defect sides within the groups over time.
*Significance, P < 0.05.
between the groups for empty, N-V, and VAS crescents. Intrarater reliability demonstrated an intraclass correlation coefficient of 0.928.
FIGURE 4. A, The BMC of sham versus defect sides for the control group.
The BMC expressed in milligrams. Asterisk indicates P = 0.042. B, The BMC
of bone graft versus defect sides for the N-V group. The BMC expressed
in milligrams. C, The BMC of bone graft versus defect sides for the VAS group.
The BMC expressed in milligrams. Asterisk indicates P = 0.032; double asterisk,
P = 0.024. Error bars represent SEM.
RESULTS
Surgeries were performed on 26 male Wistar rats (6 controls,
10 per bone graft group). Intraoperatively, the VAS bone grafts
demonstrated a pink cast similar to adjacent bone, which suggested
that vascularity was preserved from perforating dural arterioles. In
contrast, the N-V bone grafts appeared white. No postoperative complications were encountered. Micro-CT scans taken at week 0 did not
reveal any subdural or epidural collections or pneumocephalus.
Conclusions from parametric tests were confirmed using the
nonparametric analysis. The P values within this section refer to the
parametric analysis. No differences in ROI volume were seen
Week 2
Week 6
Week 12
Control
0.550
0.597
0.079
0.091
0.193
0.032*
0.042*
0.427
0.024*
N-V
VAS
Paired t-tests comparing BMC of treatment (sham or bone graft) versus defect sides
within the groups over time.
*Significance, P < 0.05.
292
FIGURE 5. The BMC differences for treatment minus defect (T-D) sides within
the groups over time. The BMC expressed in milligrams. Error bars represent
SEM. Asterisk indicates P = 0.016; double asterisk, P = 0.025.
Copyright 2014 Mutaz B. Habal, MD. Unauthorized reproduction of this article is prohibited.
ANOVA
P = 0.515
0.278
0.016*
0.025*
2
6
12
0.869
0.140
0.046*
0.077
Statistical comparisons of BMC differences for treatment minus defect (T-D) sides
between the groups.
Comparison
t-test
Wilcoxon
Week 0
Week 2
Week 6
Week 12
0.117
0.123
0.007*
0.009*
0.386
0.529
0.645
0.796
Statistical comparisons for posterior crescents on the treatment side between N-V
and VAS over time.
*Significance, P < 0.05.
t-Test, unpaired t-tests. Wilcoxon, Wilcoxon 2-sample tests.
The BMC differences for treatment minus defect (T-D) posterior crescents for the N-V and VAS groups over time are shown
in Figure 6. The T-D posterior crescent differences were greater
within the VAS versus N-V group at week 2 (P = 0.050; Table 6).
Differences for T-D posterior crescents were no longer significant
between the N-V and VAS groups at week 6 (P = 0.423) or 12
(P = 0.467).
DISCUSSION
Previous research on calvarial defect healing has largely focused on the effectiveness of scaffolds and bone substitutes.1120
Further studies have evaluated the osteogenic potential of local factors within bone graft recipient sites, including the dura, periosteum, and adjacent bone. The dura is believed to be the dominant
factor promoting revascularization and bone healing.4,21 Limited
osteogenic and angiogenic properties have been shown for adjacent
bone when bone graft healing is isolated from the dura and
Week 6
Week 12
Control vs N-V
0.043*
0.978
0.030*
0.038*
0.817
0.050*
Control vs VAS
N-V vs VAS
Post hoc Tukey honestly significant difference test to identify differences between
the 2-group comparisons after 1-way ANOVA.
*Significance, P < 0.05.
Copyright 2014 Mutaz B. Habal, MD. Unauthorized reproduction of this article is prohibited.
293
Power et al
TABLE 6. BMC Differences Between Sides Across Groups: VAS versus N-V
Comparison
t-test
Wilcoxon
Week 0
Week 2
Week 6
Week 12
0.072
0.052
0.050*
0.063
0.423
0.529
0.467
0.529
294
Copyright 2014 Mutaz B. Habal, MD. Unauthorized reproduction of this article is prohibited.
ACKNOWLEDGMENTS
The authors thank Larry Stitt for his assistance with statistical
analysis as well as Steven Pollmann and Matt Teeter for their technical support.
REFERENCES
1. Kanou M, Ueno T, Kagawa T, et al. Osteogenic potential of primed
periosteum graft in the rat calvarial model. Ann Plast Surg 2005;54:
7178
2. Inoda H, Yamamoto G, Hattori T. Histological investigation of
osteoinductive properties of rh-BMP2 in a rat calvarial bone defect
model. J Craniomaxillofac Surg 2004;32:365369
3. Honma T, Itagaki T, Nakamura M, et al. Bone formation in rat calvaria
ceases within a limited period regardless of completion of defect repair.
Oral Dis 2008;14:457464
4. Ozerdem OR, Anlatici R, Bahar T, et al. Roles of periosteum, dura, and
adjacent bone on healing of cranial osteonecrosis. J Craniofac Surg
2003;14:371379
5. Breitbart AS, Grande DA, Kessler R, et al. Tissue engineered bone
repair of calvarial defects using cultured periosteal cells. Plast Reconstr
Surg 1998;101:567574
6. Petrie Aronin CE, Cooper JA Jr, Sefcik LS, et al. Osteogenic
differentiation of dura mater stem cells cultured in vitro on
three-dimensional porous scaffolds of poly(epsilon-caprolactone)
fabricated via co-extrusion and gas foaming. Acta Biomater
2008;4:11871197
7. Park JW, Jang JH, Bae SR, et al. Bone formation with various bone graft
substitutes in critical-sized rat calvarial defect. Clin Oral Implants Res
2009;20:372378
8. Kalish BP, Schuster GS, Peacock ME, et al. Influence of
matrix-suspended demineralized bone on osseous repair using a
critical-sized defect in the rat (Rattus norvegicus) calvarium. J Oral
Implantol 2008;34:8389
9. Power SM, Matic DB, Holdsworth DW. Accounting for cranial vault
growth in experimental design. Oral Surg Oral Med Oral Pathol Oral
Radiol 2014;117:e325329
10. Gluer CC, Blake G, Lu Y, et al. Accurate assessment of precision errors:
how to measure the reproducibility of bone densitometry techniques.
Osteoporos Int 1995;5:262270
11. Sikavitsas VI, van den Dolder J, Bancroft GN, et al. Influence of the in
vitro culture period on the in vivo performance of cell/titanium bone
tissue-engineered constructs using a rat cranial critical size defect
model. J Biomed Mater Res A 2003;67:944951
12. Bolgen N, Vargel I, Korkusuz P, et al. Tissue responses to novel tissue
engineering biodegradable cryogel scaffolds: an animal model.
J Biomed Mater Res A 2009;91:6068
13. Burdick JA, Frankel D, Dernell WS, et al. An initial investigation of
photocurable three-dimensional lactic acid based scaffolds in a
critical-sized cranial defect. Biomaterials 2003;24:
16131620
14. Castano-Izquierdo H, Alvarez-Barreto J, van den Dolder J, et al.
Pre-culture period of mesenchymal stem cells in osteogenic media
influences their in vivo bone forming potential. J Biomed Mater Res A
2007;82:129138
15. Cowan CM, Aghaloo T, Chou YF, et al. MicroCT evaluation of
three-dimensional mineralization in response to BMP-2 doses in vitro
and in critical sized rat calvarial defects. Tissue Eng 2007;13:501512
16. Petrie Aronin CE, Sadik KW, Lay AL, et al. Comparative effects of
scaffold pore size, pore volume, and total void volume on cranial bone
healing patterns using microsphere-based scaffolds.
J Biomed Mater Res A 2009;89:632641
17. Woodruff MA, Rath SN, Susanto E, et al. Sustained release and
osteogenic potential of heparan sulfate-doped fibrin glue scaffolds
within a rat cranial model. J Mol Histol 2007;38:425433
18. Sawyer AA, Song SJ, Susanto E, et al. The stimulation of healing within
a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with
rhBMP-2. Biomaterials 2009;30:24792488
Copyright 2014 Mutaz B. Habal, MD. Unauthorized reproduction of this article is prohibited.
295